True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis

Haematologica. 2018 Aug;103(8):e374-e376. doi: 10.3324/haematol.2018.190405. Epub 2018 Apr 19.

Authors

Avinainder Singh¹, Hallie I Geller¹, Kevin M Alexander¹, Robert F Padera², Richard N Mitchell², Sharmila Dorbala¹, Jorge J Castillo³, Rodney H Falk⁴

Affiliations

¹ Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
² Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
³ Bing Center for Waldenstrom's Macroglobulinemia, Dana Faber Cancer Institute, Boston, MA, USA.
⁴ Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA rfalk@bwh.harvard.edu.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Amyloid Neuropathies, Familial / complications*
Amyloid Neuropathies, Familial / diagnosis
Cardiomyopathies
Female
Humans
Immunoglobulin M / blood
Male
Mass Spectrometry / methods
Radionuclide Imaging / methods
Technetium
Waldenstrom Macroglobulinemia / complications*
Waldenstrom Macroglobulinemia / diagnosis

Substances

Immunoglobulin M
Technetium

Supplementary concepts

Amyloidosis, Hereditary, Transthyretin-Related

Grants and funding

T32 HL007604/HL/NHLBI NIH HHS/United States